Literature DB >> 24972636

Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor.

Elisabetta Rovida1, Persio Dello Sbarba.   

Abstract

Receptor tyrosine kinases (RTK) have long being studied with respect to the "canonical" signaling. This includes ligand-induced activation of a receptor tyrosine kinase at the cell surface that leads to receptor dimerization, followed by its phosphorylation in the intracellular domain and activation. The activated receptor then recruits cytoplasmic signaling molecules including other kinases. Activation of the downstream signaling cascade frequently leads to changes in gene expression following nuclear translocation of downstream targets. However, RTK themselves may localize within the nucleus, as either full-length molecules or cleaved fragments, with or without their ligands. Significant differences in this mechanism have been reported depending on the individual RTK, cellular context or disease. Accumulating evidences indicate that the colony-stimulating factor-1 receptor (CSF-1R) may localize within the nucleus. To date, however, little is known about the mechanism of CSF-1R nuclear shuttling, as well as the functional role of nuclear CSF-1R.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24972636     DOI: 10.1007/s00018-014-1668-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  32 in total

Review 1.  Nuclear localization and possible functions of receptor tyrosine kinases.

Authors:  Graham Carpenter
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

2.  CSF-1 and TPA stimulate independent pathways leading to lysosomal degradation or regulated intramembrane proteolysis of the CSF-1 receptor.

Authors:  Gary Glenn; Peter van der Geer
Journal:  FEBS Lett       Date:  2007-10-29       Impact factor: 4.124

Review 3.  Colony-stimulating factor-1 receptor.

Authors:  C J Sherr
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

4.  Modulation of receptors for the colony-stimulating factor, CSF-1, by bacterial lipopolysaccharide and CSF-1.

Authors:  L J Guilbert; E R Stanley
Journal:  J Immunol Methods       Date:  1984-10-12       Impact factor: 2.303

5.  IFN-gamma/lipopolysaccharide activation of macrophages is associated with protein kinase C-dependent down-modulation of the colony-stimulating factor-1 receptor.

Authors:  M Baccarini; P Dello Sbarba; D Buscher; A Bartocci; E R Stanley
Journal:  J Immunol       Date:  1992-10-15       Impact factor: 5.422

6.  Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation.

Authors:  Gabriele Wanner; Claus Mayer; Rainer Kehlbach; H Peter Rodemann; Klaus Dittmann
Journal:  Radiother Oncol       Date:  2007-11-26       Impact factor: 6.280

7.  Lipopolysaccharide inhibits the binding of colony-stimulating factor (CSF-1) to murine peritoneal exudate macrophages.

Authors:  B D Chen; H S Lin; S Hsu
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

8.  Tumor-promoting phorbol esters inhibit the binding of colony-stimulating factor (CSF-1) to murine peritoneal exudate macrophages.

Authors:  B D Chen; H S Lin; S Hsu
Journal:  J Cell Physiol       Date:  1983-08       Impact factor: 6.384

9.  The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines.

Authors:  Andrea Morandi; Valentina Barbetti; Maria Riverso; Persio Dello Sbarba; Elisabetta Rovida
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

10.  Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells.

Authors:  V Barbetti; A Morandi; I Tusa; G Digiacomo; M Riverso; I Marzi; M G Cipolleschi; S Bessi; A Giannini; A Di Leo; P Dello Sbarba; E Rovida
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

View more
  1 in total

1.  Overexpression of macrophage-colony stimulating factor-1 receptor as a prognostic factor for survival in cancer: A systematic review and meta-analysis.

Authors:  Huaqing Mo; Yanrong Hao; Yanru Lv; Zenan Chen; Jingyi Shen; Shu Zhou; MengJie Yin
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.